SignalXSignalX

DYN Dyne Therapeutics, Inc.

8-K Current Report
Filed: March 2, 2026
Health Care
Pharmaceutical Preparations
Dyne Therapeutics, Inc. Overview

Dyne Therapeutics, Inc. (DYN) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Full-year 2025 financial results announced March 2, 2026; details in Exhibit 99.1 press release
  • • Filing furnished (not filed) — limits legal liability but does not affect investor relevance of results
+1 more insights

Get deeper insights on Dyne Therapeutics, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.